Rosecrance Jackson Centers Women’s Center

Rosecrance Jackson Centers Women’s Center (Le Mars, IA) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility's programming is outpatient (IOP, MAT), not residential. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Rosecrance Jackson Centers Women’s Center

Rosecrance Jackson Centers Women’s Center is an outpatient-focused program (IOP, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Rosecrance Jackson Centers Women’s Center's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Rosecrance Jackson Centers Women’s Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Pre-admission documentation for Rosecrance Jackson Centers Women’s Center should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.